Alembic Pharmaceuticals Ltd Corporate Actions

Alembic Pharma Gets USFDA Approval for Diltiazem ER Capsules

 Copy Link

Alembic Pharmaceuticals continues to grow its footprint in the US, with this approval contributing to its robust portfolio of generic medications.

Alembic Pharma's Gujarat plant clears USFDA inspection

 Copy Link

The business stated that the authorised ANDA is therapeutically similar to the reference-listed drug product (RLD) Lastacaft Solution.

Alembic Pharma Shares Jump on USFDA Approval for Lamotrigine Tablets

 Copy Link

The approved Lamotrigine Extended-Release tablets are therapeutic equivalents of GlaxoSmithKline's Lamictal XR, with strengths of 200 mg, 250 mg, and 300 mg.

Alembic Pharmaceuticals Gets US FDA Approval for Dabigatran Etexilate Capsules

 Copy Link

Alembic Pharmaceuticals has got the final approval from USFDA for Dabigatran Etexilate Capsules, 110 mg.

Alembic Pharma's Luphenazine Tablets Get USFDA Nod

 Copy Link

Alembic has 210 ANDA approvals from the USFDA, including 182 final approvals and 28 tentative clearances.

Alembic Pharma receives USFDA nod for generic Selexipag Injection

 Copy Link

This certification allows a company to apply for approval of a generic drug before the patents of the brand-name drug expire.

Top 10 stocks for today – 15th July, 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.

Top 10 stocks for today – 11th July 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: SBI, Sula Vineyards, Zydus Lifesciences, Kesoram Industries, etc.